Research from Water Tower Research, Water Tower Research

Water Tower Research

Research from Water Tower Research

Water Tower Research is a leading equity research firm that provides research on micro, small and mid cap companies.

Water Tower Research was founded by Wall Street veterans after witnessing a fundamental shift in the investment research industry with the result being a declining knowledge base among investors, a lack of awareness and a shrinking pool of fundamental research being conducted on companies across the small-cap and micro-cap spectrum. The same issues are now increasingly occurring in the mid-cap space. This sea change within the investment community is impacting not only the companies themselves but also current shareholders and potential investors. With significantly less active sell-side sponsorship by Wall Street, a substantial information gap has developed between companies and various constituents in the financial community. The net result is fewer channels for insight and information to flow between companies and investors.

Equity Research Firm

Thematic (Sector/Industry)

<ul><li>Semiconductors reclaimed the lead in September.</li><li>The WTR AI Index rose 3.0% M/M, above the S&amp;P 500 (down 0.5%) and the Russell 2000 (down 5.4%) and in line with the Nasdaq (up 3.2%).</li><li>Semiconductors (20% of the index) jumped 14.5% and accounted for most of the index’s gain, while Software (23%) slipped 1.0%, Internet and Data Services (8%) rose 2.9%, Other Tech (23%) rose 2.6%, and Other Industries (26%) fell 0.9%.</li></ul>

Semiconductors reclaimed the lead in September.The WTR AI Index rose 3.0% M/M, above the S&amp;P 500 (down 0.5%) and the Russell 2000 (down 5.4%) and in line with the Nasdaq (up 3.2%).Semiconductors (20% of the index) jumped 14.5% and accounted for most of the index’s gain, while Software (23%) slipped 1.0%, Internet and Data Services (8%) rose 2.9%, Other Tech (23%) rose 2.6%, and Other Industries (26%) fell 0.9%.

AI Flow Index : Sailing a Sea of Companies in AI - 5 October 2026

United States

Pacific Biosciences of California Inc. has developed a novel approach to studying the synthesis and regulation of DNA, RNA and protein.  The Company's system enables real-time analysis of biomolecules with single molecule resolution.

Pacific Biosciences Of California (PACB US)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00